Alamar Biosciences vs Tempus
Side-by-side comparison of AI visibility scores, market position, and capabilities
Alamar Biosciences develops the NULISA proteomics platform for ultrasensitive protein biomarker detection from minimal sample volumes; enables early disease detection and drug development research;
About
Alamar Biosciences is a Fremont, California-based life sciences company founded in 2020 with a focus on advancing proteomics through ultrasensitive biomarker detection technology. The company's flagship platform, NULISA (Nucleic acid-Linked Immuno-Sandwich Assay), enables researchers to simultaneously measure hundreds of protein biomarkers from very small sample volumes — including blood, cerebrospinal fluid, and other biological matrices — with sensitivity orders of magnitude beyond conventional assays like ELISA. This capability is critical for detecting disease-associated proteins at very early stages before symptoms manifest.
Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.
About
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.